Frontlight ResearchEarly access
Trial site
Fondazione Policlinico Tor Vergata
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Myelodysplastic syndromes1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Amgen1 trial
- Eli Lilly and Company1 trial
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 trial
- Janssen Research & Development, LLC1 trial
- Kedrion S.p.A.1 trial
Running trials
Active, not recruiting
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026